EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
Pre-publication versions of this article are available by contacting email@example.com.
|7 Jan 2016||Submitted||Original manuscript|
|29 Sep 2015||Reviewed||Reviewer Report - Bernard Zonnenberg|
|23 Nov 2015||Reviewed||Reviewer Report - Darcy Krueger|
|11 Mar 2016||Reviewed||Reviewer Report - John Lawson|
|11 Apr 2016||Reviewed||Reviewer Report - Deepti Dubey|
|2 Jun 2016||Author responded||Author comments - Andras Fogarasi|
|Resubmission - Version 2|
|2 Jun 2016||Submitted||Manuscript version 2|
|6 Jun 2016||Reviewed||Reviewer Report - Deepti Dubey|
|19 Jul 2016||Author responded||Author comments - Andras Fogarasi|
|Resubmission - Version 3|
|19 Jul 2016||Submitted||Manuscript version 3|
|2 Aug 2016||Editorially accepted|
|8 Aug 2016||Article published||10.1186/s12883-016-0658-4|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.